Abstract
Objectives The determination of the volume of brain lesions after trauma is challenging. Manual delineation is observer-dependent and time-consuming which inhibits the practice in clinical routine. We propose and evaluate an automated atlas-based quantification procedure (AQP) based on the detection of abnormal mean diffusivity (MD) values computed from diffusion-weighted MR images.
Methods We measured the performance of AQP versus manual delineation consensus by independent raters in two series of experiments: i) realistic trauma phantoms (n=5) where abnormal MD values were assigned to healthy brain images according to the intensity, form and location of lesion observed in real TBI cases; ii) severe TBI patients (n=12 patients) who underwent MR imaging within 10 days after injury.
Results In realistic trauma phantoms, no statistical difference in Dice similarity coefficient, precision and brain lesion volumes was found between AQP, the rater consensus and the ground truth lesion delineations. Similar findings were obtained when comparing AQP and manual annotations for TBI patients. The intra-class correlation coefficient between AQP and manual delineation was 0.70 in realistic phantoms and 0.92 in TBI patients. The volume of brain lesions detected in TBI patients was 59 ml (19-84 ml) (median; 25-75th centiles).
Conclusions our results indicate that an automatic quantification procedure could accurately determine with accuracy the volume of brain lesions after trauma. This presents an opportunity to support the individualized management of severe TBI patients.
Key points
The management of patients with severe traumatic brain injury is complex, and access to objective quantitative information lesion volumes can support clinical decision-making.
An automated delineation procedure was developed to determine the nature and volume of brain lesions post-trauma.
This procedure was based on diffusion weighted MR-imaging to quantify the volume of vasogenic and cellular edema from realistic phantoms and patients with severe traumatic brain injury.
Nature and quantification of the brain lesions volume compared favorably with manual delineation of brain lesions by a panel of experts.
Competing Interest Statement
F. Forbes and M. Dojat declare relationships with the company: Pixyl.
Clinical Trial
OxyTC, NCT02754063
Funding Statement
CM was recipient of a grant from the Gueules Cassees foundation. Grenoble MRI facility IRMaGe was partly funded by the French program Investissement d'avenir run by the Agence Nationale de la Recherche: grant Infrastructure d'avenir en Biologie Sante ANR-11-INBS-0006. The French Remi network was financially supported by grants from France Life Imaging: grants C7H-FLI11B23 and C7H-FLI11B19.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the local ethical committee (Comite de Protection des Personnes Sud-Est V, ID RCB-2014-A01674-43) and registered with ClinicalTrial.gov (OxyTC, NCT02754063).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
T. Mistral: tmistral{at}chu-grenoble.fr; P. Rocca: pauline.roca{at}pixyl.ai; C. Maggia: ; A. Tucholka: alan.tucholka{at}pixyl.ai; F. Forbes: florence.forbes{at}inria.fr; S. Doyle : senan.doyle{at}pixyl.ai; A. Krainik : AKrainik{at}chu-grenoble.fr; D. Galanaud: galanaud{at}gmail.com; E. Schmitt: e.schmitt{at}chu-nancy.fr; S. Kremer: stephane.kremer{at}chru-strasbourg.fr; A. Kastler: akastler{at}chu-grenoble.fr; I. Troprès: irene.tropres{at}univ-grenoble-alpes.fr; E. L. Barbier: emmanuel.barbier{at}univ-grenoble-alpes.fr; JF Payen: jfpayen{at}chu-grenoble.fr
Data Availability
MR data supporting the results of this study are available from the corresponding author, on a collaborative basis.
Abbreviations
- (ASSD)
- Average Symmetrical Surface Distance
- AQP
- Automatic Quantification Procedure
- DWI
- Diffusion Weighted Imaging
- GT
- Ground Truth
- (HD)
- Hausdorff Distance
- (ICC)
- ntra-class Correlation Coefficient
- MD
- Mean Diffusivity
- SM
- Supplementary Material
- TBI
- Train Brain injury